Sherlock Biosciences Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Sherlock Biosciences is a biotechnology research company based at 40 Guest Street in Boston, Massachusetts, employing 11 to 50 people. On July 1, 2024, Sherlock Biosciences was acquired by OraSure Technologies and became a subsidiary. Its work centers on enabling broader access to testing to support personalized healthcare and global health initiatives. In 2023 the company expanded its operations with a biomanufacturing facility in the United Kingdom and formed a collaboration with the Gloucester Marine Genomics Institute to develop a diagnostic tool under a USDA SBIR Phase I award. Sherlock has pursued CRISPR-based diagnostics and related platforms, including launching a free AI-based operating system for CRISPR diagnostics development in 2023.